Kala Kumar Bharani

1.4k total citations · 1 hit paper
27 papers, 954 citations indexed

About

Kala Kumar Bharani is a scholar working on Molecular Biology, Infectious Diseases and Materials Chemistry. According to data from OpenAlex, Kala Kumar Bharani has authored 27 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Infectious Diseases and 4 papers in Materials Chemistry. Recurrent topics in Kala Kumar Bharani's work include COVID-19 Clinical Research Studies (4 papers), Advanced Nanomaterials in Catalysis (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Kala Kumar Bharani is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), Advanced Nanomaterials in Catalysis (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Kala Kumar Bharani collaborates with scholars based in India, Germany and United States. Kala Kumar Bharani's co-authors include Amit Khurana, Prince Allawadhi, Anil Kumar Banothu, Isha Khurana, Ralf Weiskirchen, Vishakha Singh, Umashanker Navik, Sachin Allwadhi, Kamaldeep Joshi and Deepak Chhabra and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Carbohydrate Polymers.

In The Last Decade

Kala Kumar Bharani

27 papers receiving 944 citations

Hit Papers

Gene therapy: Comprehensive overview and therapeutic appl... 2022 2026 2023 2024 2022 50 100 150

Peers

Kala Kumar Bharani
Kala Kumar Bharani
Citations per year, relative to Kala Kumar Bharani Kala Kumar Bharani (= 1×) peers Prince Allawadhi

Countries citing papers authored by Kala Kumar Bharani

Since Specialization
Citations

This map shows the geographic impact of Kala Kumar Bharani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kala Kumar Bharani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kala Kumar Bharani more than expected).

Fields of papers citing papers by Kala Kumar Bharani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kala Kumar Bharani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kala Kumar Bharani. The network helps show where Kala Kumar Bharani may publish in the future.

Co-authorship network of co-authors of Kala Kumar Bharani

This figure shows the co-authorship network connecting the top 25 collaborators of Kala Kumar Bharani. A scholar is included among the top collaborators of Kala Kumar Bharani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kala Kumar Bharani. Kala Kumar Bharani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bharani, Kala Kumar, et al.. (2025). The role of Ashwagandha in modulating gut parameters in dogs—a randomized double-blind placebo-controlled trial. Frontiers in Veterinary Science. 11. 1491989–1491989. 1 indexed citations
2.
Bharani, Kala Kumar, et al.. (2024). Safety assessment of rat embryonic fraction for in vivo regenerative therapy. Biology Open. 13(8). 1 indexed citations
4.
Bharani, Kala Kumar, et al.. (2024). Effects of ashwagandha ( Withania somnifera ) root extract on aging‐related changes in healthy geriatric dogs: A randomized, double‐blinded placebo‐controlled study. Veterinary Medicine and Science. 10(5). e1556–e1556. 4 indexed citations
5.
Lee, Vivian K., Taewoo Lee, Tanmoy Saha, et al.. (2024). An architecturally rational hemostat for rapid stopping of massive bleeding on anticoagulation therapy. Proceedings of the National Academy of Sciences. 121(5). e2316170121–e2316170121. 13 indexed citations
6.
Bharani, Kala Kumar, et al.. (2024). Adaptogenic Ashwagandha root extract modulates inflammatory markers in feline stress management: a double-blind placebo-controlled clinical trial. Journal of Applied Animal Research. 52(1). 5 indexed citations
7.
Khurana, Amit, Prince Allawadhi, Sachin Allwadhi, et al.. (2023). Antimicrobial and anti-viral effects of selenium nanoparticles and selenoprotein based strategies: COVID-19 and beyond. Journal of Drug Delivery Science and Technology. 86. 104663–104663. 15 indexed citations
8.
Banothu, Anil Kumar, et al.. (2022). Vincamine, an active constituent of Vinca rosea ameliorates experimentally induced acute lung injury in Swiss albino mice through modulation of Nrf-2/NF-κB signaling cascade. International Immunopharmacology. 108. 108773–108773. 17 indexed citations
9.
Banothu, Anil Kumar, et al.. (2022). Tropolone derivative hinokitiol ameliorates cerulein-induced acute pancreatitis in mice. International Immunopharmacology. 109. 108915–108915. 15 indexed citations
10.
Sayed, Nilofer, Prince Allawadhi, Amit Khurana, et al.. (2022). Gene therapy: Comprehensive overview and therapeutic applications. Life Sciences. 294. 120375–120375. 186 indexed citations breakdown →
11.
Allawadhi, Prince, Vishakha Singh, Amit Khurana, et al.. (2021). Silver nanoparticle based multifunctional approach for combating COVID-19. Sensors International. 2. 100101–100101. 65 indexed citations
12.
Kalkal, Ashish, Prince Allawadhi, Rangadhar Pradhan, et al.. (2021). Allium sativum derived carbon dots as a potential theranostic agent to combat the COVID-19 crisis. Sensors International. 2. 100102–100102. 40 indexed citations
13.
Singh, Vishakha, Prince Allawadhi, Amit Khurana, Anil Kumar Banothu, & Kala Kumar Bharani. (2021). Critical neurological features of COVID-19: Role of imaging methods and biosensors for effective diagnosis. Sensors International. 2. 100098–100098. 22 indexed citations
15.
Singh, Vishakha, Amit Khurana, Prince Allawadhi, et al.. (2021). Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases. Frontiers in Pharmacology. 12. 790963–790963. 22 indexed citations
16.
Allawadhi, Prince, Vishakha Singh, Isha Khurana, et al.. (2021). Biomedical applications of polysaccharide nanoparticles for chronic inflammatory disorders: Focus on rheumatoid arthritis, diabetes and organ fibrosis. Carbohydrate Polymers. 281. 118923–118923. 69 indexed citations
17.
Khurana, Amit, Prince Allawadhi, Isha Khurana, et al.. (2021). Role of nanotechnology behind the success of mRNA vaccines for COVID-19. Nano Today. 38. 101142–101142. 191 indexed citations
18.
Allawadhi, Prince, Amit Khurana, Sachin Allwadhi, et al.. (2020). Potential of electric stimulation for the management of COVID-19. Medical Hypotheses. 144. 110259–110259. 23 indexed citations
19.
Allawadhi, Prince, Amit Khurana, Sachin Allwadhi, et al.. (2020). Nanoceria as a possible agent for the management of COVID-19. Nano Today. 35. 100982–100982. 67 indexed citations
20.
Saleem, T.S. Mohamed, et al.. (2009). Phyto-pharmacological review of Sesamum indicum Linn.. 5(4). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026